WO2002087630A3 - Determination of gastric and oesophageal tumours - Google Patents

Determination of gastric and oesophageal tumours

Info

Publication number
WO2002087630A3
WO2002087630A3 PCT/EP2002/004242 EP0204242W WO02087630A3 WO 2002087630 A3 WO2002087630 A3 WO 2002087630A3 EP 0204242 W EP0204242 W EP 0204242W WO 02087630 A3 WO02087630 A3 WO 02087630A3
Authority
WO
WIPO (PCT)
Prior art keywords
gastric
determination
oesophageal
tumours
oesophageal tumours
Prior art date
Application number
PCT/EP2002/004242
Other languages
French (fr)
Other versions
WO2002087630A2 (en
Inventor
Leo Alfredo Di
Michelle Linsalata
Francesco Russo
Original Assignee
Eurospital S P A
Leo Alfredo Di
Michelle Linsalata
Francesco Russo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurospital S P A, Leo Alfredo Di, Michelle Linsalata, Francesco Russo filed Critical Eurospital S P A
Priority to AU2002302542A priority Critical patent/AU2002302542A1/en
Publication of WO2002087630A2 publication Critical patent/WO2002087630A2/en
Publication of WO2002087630A3 publication Critical patent/WO2002087630A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1206—Administration of radioactive gases, aerosols or breath tests

Abstract

A method for the diagnosis of gastric and oesophageal tumors in human patients which comprises 1) administration of 13C ornithine or a metabolically active precursor thereof, and 2) quantitation of the ¿13?CO2 in the breath.
PCT/EP2002/004242 2001-04-27 2002-04-17 Determination of gastric and oesophageal tumours WO2002087630A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002302542A AU2002302542A1 (en) 2001-04-27 2002-04-17 Determination of gastric and oesophageal tumours

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI01A000885 2001-04-27
IT2001MI000885A ITMI20010885A1 (en) 2001-04-27 2001-04-27 METHOD FOR THE DETERMINATION OF GASTRIC AND ESOPHAGEAL NEOPLASIES

Publications (2)

Publication Number Publication Date
WO2002087630A2 WO2002087630A2 (en) 2002-11-07
WO2002087630A3 true WO2002087630A3 (en) 2003-10-16

Family

ID=11447564

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2002/004242 WO2002087630A2 (en) 2001-04-27 2002-04-17 Determination of gastric and oesophageal tumours

Country Status (3)

Country Link
AU (1) AU2002302542A1 (en)
IT (1) ITMI20010885A1 (en)
WO (1) WO2002087630A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2442980B (en) * 2006-10-18 2011-11-23 Autoliv Dev Improvements in or relating to detection of substances in a subject
GB0803477D0 (en) * 2008-02-26 2008-04-02 Ge Healthcare As Therapy selection method

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0911040A1 (en) * 1997-10-06 1999-04-28 Tokyo Gas Co., Ltd. Diagnostic agent for liver function
EP0913161A2 (en) * 1997-10-21 1999-05-06 Tokyo Gas Co., Ltd. Diagnostic agent for diabetes

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0911040A1 (en) * 1997-10-06 1999-04-28 Tokyo Gas Co., Ltd. Diagnostic agent for liver function
EP0913161A2 (en) * 1997-10-21 1999-05-06 Tokyo Gas Co., Ltd. Diagnostic agent for diabetes

Also Published As

Publication number Publication date
ITMI20010885A0 (en) 2001-04-27
ITMI20010885A1 (en) 2002-10-27
AU2002302542A1 (en) 2002-11-11
WO2002087630A2 (en) 2002-11-07

Similar Documents

Publication Publication Date Title
WO2005000161A3 (en) Methods and devices for occluding body lumens and/or for delivering therapeutic agents
WO2002094200A3 (en) Pulmonary administration of chemically modified insulin
WO2004021869A3 (en) Systems and methods for moving and/or restraining tissue in the upper respiratory system
WO2004112711A3 (en) Oral extended-release composition
WO2002100390A3 (en) Improved method of treating the syndrome of coronary heart disease risk factors in humans
CA2362499A1 (en) Combinations of formoterol and mometasone furoate for asthma
CA2386690A1 (en) Pharmaceutical tramadol salts
AU2003202929A1 (en) A multi-modality apparatus for dynamic anatomical, physiological and molecular imaging
WO2004023974A3 (en) Apparatus and method for non-invasive measurement of blood constituents
AU5562101A (en) Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
WO2004066805A3 (en) In vivo device for improving diastolic ventricular function
WO2002047668A3 (en) Novel medicament compositions based on anticholinesterase drugs and on ciclesonides
AU2002317366A1 (en) Respiration and heart rate monitor
CA2294921A1 (en) Levobupivacaine and its use
AU2001264042A1 (en) 1,4-diazabicyclo(3.2.2)nonane-phenylisoxazole derivatives, preparation and therapeutic use thereof
ZA200208761B (en) Pharmaceutical form of administration for peptides, methods for its production and use.
WO2005044187A3 (en) Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same
AU2003246567A1 (en) Administration form for the oral administration of active substances, vitamins, and/or nutrients
AU3598299A (en) Improved compositions for inhalation
WO2002087630A3 (en) Determination of gastric and oesophageal tumours
MY130445A (en) Novel formulations of alpha-2, 4-disulfophenyl-n-tert-butylnitrone
HUP0303597A3 (en) Diposable vaginal cannula for the simultaneous administration of drugs in different forms
WO2001060343A3 (en) Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid and/or physiologically compatible salts thereof for producing a medicament for treating cancers
CA2396209A1 (en) The use of mirtazapine for the treatment of sleep disorders
AU2003246566A1 (en) Administration form for the oral administration of active substances, vitamins, and/or nutrients

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP